Trifluridine/tipiracil (TAS-102) in refractory metastatic colorectal cancer: A multicenter register in the frame of the Italian compassionate use program

May 24, 2018

Trifluridine/tipiracil (TAS-102) in refractory metastatic colorectal cancer: A multicenter register in the frame of the Italian compassionate use program

Published on 05/23/2018

previous post: Alcohol and opioid use in chronic pain: A cross-sectional examination of differences in functioning based on misuse status
next post: Trends in the clinical presentation, treatment, and survival for pancreatic adenocarcinoma